Increases in ATX-LPA-LPA1 signaling are linked to multiple fibrotic diseases, including idiopathic pulmonary fibrosis [11], chronic liver diseases [10], renal interstitial fibrosis [88], and scleroderma [89]. The gene discussed is ENPP2; the disease is pulmonary fibrosis.